Literature DB >> 8677489

Cerebral aneurysm in the HIV patient: a report of six cases.

A H Maniker1, C D Hunt.   

Abstract

BACKGROUND: In view of the almost certain mortality of the acquired immune deficiency syndrome (AIDS) patient, controversy may arise as to how to treat those individuals with concomitant aneurysmal disease.
METHODS: We conducted a retrospective case review of six patients seen in a 1-year period, who had a history of either being positive for human immunodeficiency virus (HIV) or prior opportunistic pneumonias and who, therefore, by Centers for Disease Control definition, have frank AIDS. The patients, who were in otherwise stable health, presented with subarachnoid hemorrhage from angiographically demonstrated ruptured berry aneurysms.
RESULTS: There was no increased incidence of postoperative infections and the quality of life of the surviving five patients was quite good.
CONCLUSIONS: In a patient in stable health, the diagnosis of HIV infection should not necessarily preclude the established regimen for the treatment of aneurysmal disease.

Entities:  

Mesh:

Year:  1996        PMID: 8677489     DOI: 10.1016/0090-3019(96)00030-4

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  7 in total

Review 1.  HIV and cerebral aneurysms.

Authors:  Ketan R Bulsara; Ali Raja; Justin Owen
Journal:  Neurosurg Rev       Date:  2004-12-24       Impact factor: 3.042

2.  Arterial dissection and subarachnoid haemorrhage in human immunodeficiency virus-infected patients. A report of three cases.

Authors:  A Taylor; D Lefeuvre; A Levy; S Candy
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

3.  Aneurysmal vasculopathy in human-acquired immunodeficiency virus-infected adults: Imaging case series and review of the literature.

Authors:  Jayesh P Thawani; Nikhil R Nayak; Jared M Pisapia; Dmitriy Petrov; Bryan A Pukenas; Robert W Hurst; Michelle J Smith
Journal:  Interv Neuroradiol       Date:  2015-05-28       Impact factor: 1.610

4.  Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration.

Authors:  Erik R Kline; Dean J Kleinhenz; Bill Liang; Sergey Dikalov; David M Guidot; C Michael Hart; Dean P Jones; Roy L Sutliff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

Review 5.  The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction.

Authors:  Erik R Kline; Roy L Sutliff
Journal:  J Investig Med       Date:  2008-06       Impact factor: 2.895

Review 6.  HIV-1, reactive oxygen species, and vascular complications.

Authors:  Kristi M Porter; Roy L Sutliff
Journal:  Free Radic Biol Med       Date:  2012-04-21       Impact factor: 7.376

7.  Current Efavirenz (EFV) or ritonavir-boosted lopinavir (LPV/r) use correlates with elevate markers of atherosclerosis in HIV-infected subjects in Addis Ababa, Ethiopia.

Authors:  Rudolph L Gleason; Alexander W Caulk; Daniel Seifu; Ivana Parker; Brani Vidakovic; Helena Getenet; Getachew Assefa; Wondwossen Amogne
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.